SciELO - Scientific Electronic Library Online

 
vol.14 número3Hallazgos citoquímicos en líquido pleural de pacientes con COVID-19, atendidos en un servicio de emergencia índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

  • No hay articulos citadosCitado por SciELO

Links relacionados

  • No hay articulos similaresSimilares en SciELO

Compartir


Revista del Cuerpo Médico Hospital Nacional Almanzor Aguinaga Asenjo

versión impresa ISSN 2225-5109versión On-line ISSN 2227-4731

Resumen

CIEZA-YAMUNAQUE, Liliana et al. Evolution and management of the pediatric multi-systemic inflammatory syndrome associated with SARS CoV-2 infection in a pediatric ICU in Lima, Peru. Rev. Cuerpo Med. HNAAA [online]. 2021, vol.14, n.3, pp.262-266.  Epub 26-Nov-2021. ISSN 2225-5109.  http://dx.doi.org/10.35434/rcmhnaaa.2021.143.1216.

Background:

Pediatric Multisystemic Inflammatory Syndrome (SIMP) associated with SARS CoV2 seriously affects children.

Objective:

To describe the symptoms, treatment and evolution of SIMP in patients of a reference Pediatric Intensive Care Unit (PICU).

Findings:

18 children were identified with a mean age of 8.76 years, 50% male, all with a positive serological test. The most frequent manifestations were: fever (100%), respiratory distress (94%), abdominal pain (89%), elevated C-reactive protein (average 21.8), thrombocytopenia (50%), pathological chest X-ray (89%) and depressed myocardial contractility (61%). 72% required invasive mechanical ventilation (average 3 days) and catecholamines; 89% used corticosteroids plus immunoglobulins. The average stay in the PICU was 5.5 days. One patient died of intracerebral hemorrhage.

Conclusions:

SIMP in PICU is characterized by fever, respiratory distress, abdominal pain, elevated inflammatory markers, and myocardial depression. Requiring corticosteroids, immunoglobulin and ventilatory support; presenting intermediate stay and low mortality.

Palabras clave : Covid-19; lymphonodular mucocutaneous syndrome; critical care; child; Therapeutics; Peru.

        · resumen en Español     · texto en Español     · Español ( pdf )